NRG-GU012, the SAMURAI Study, with Dr. William A. Hall episode artwork

EPISODE · Mar 11, 2025 · 34 MIN

NRG-GU012, the SAMURAI Study, with Dr. William A. Hall

from The NRG Oncology Podcast · host NRG Oncology

Our co-hosts discuss the currently active & accruing NRG-GU012 study, also known as the "SAMURAI" study. This study is assessing if stereotactic ablative radiotherapy to the primary tumor in combination with immunotherapy improves outcomes when compared to immunotherapy by itself for patients who have metastatic, unresected, renal cell carcinoma.

Our co-hosts discuss the currently active & accruing NRG-GU012 study, also known as the "SAMURAI" study. This study is assessing if stereotactic ablative radiotherapy to the primary tumor in combination with immunotherapy improves outcomes when compared to immunotherapy by itself for patients who have metastatic, unresected, renal cell carcinoma.

NOW PLAYING

NRG-GU012, the SAMURAI Study, with Dr. William A. Hall

0:00 34:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The NRG Oncology Podcast?

This episode is 34 minutes long.

When was this The NRG Oncology Podcast episode published?

This episode was published on March 11, 2025.

What is this episode about?

Our co-hosts discuss the currently active & accruing NRG-GU012 study, also known as the "SAMURAI" study. This study is assessing if stereotactic ablative radiotherapy to the primary tumor in combination with immunotherapy improves outcomes when...

Can I download this The NRG Oncology Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!